Hypertension affects 1 in 3 adults globally and is the leading modifiable risk factor for cardiovascular disease. Aldosterone dysregulation, often driven by obesity and primary aldosteronism, affects ...
Aldosterone synthase inhibitor lorundrostat found to safely lower blood pressure in a clinical trial
A team of medical researchers and doctors affiliated with multiple institutions in the U.S. has found, via clinical trial, that the aldosterone synthase inhibitor lorundrostat is likely safe to use ...
Patients presenting with nonspecific symptoms such as nausea, vomiting, headache, and muscle pain may have an underlying electrolyte disorder. Hyponatremia, the most common electrolyte abnormality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results